Please login to the form below

Not currently logged in
Email:
Password:

Pascal Soriot

This page shows the latest Pascal Soriot news and features for those working in and with pharma, biotech and healthcare.

Lynparza cleared as ovarian cancer maintenance therapy on Cancer Drugs Fund

Lynparza cleared as ovarian cancer maintenance therapy on Cancer Drugs Fund

CDF. This prompted AstraZeneca chief executive Pascal Soriot to call for a ‘comprehensive review of how NICE values innovative medicines.’ NICE has this week launched such a review, although a reconsideration

Latest news

More from news
Approximately 1 fully matching, plus 87 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Alzheimers incidence
A roadmap to the successful treatment of Alzheimer’s disease
Building on past research to learn more about the disease and how to treat it...
Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...

Infographics